🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 10 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/11/1994 44,92 44,92 41,17 42,11 +0,00% 8,33% 3.313
18/11/1994 42,11 44,92 42,11 42,11 -6,25% 6,67% 3.420
17/11/1994 42,11 44,92 42,11 44,92 +0,00% 6,67% 6.332
16/11/1994 44,92 44,92 44,92 44,92 +0,00% 0,00% 1.229
15/11/1994 42,11 44,92 42,11 44,92 +6,67% 6,67% 828
14/11/1994 43,04 43,04 41,17 42,11 +2,27% 4,35% 1.924
11/11/1994 41,17 42,58 41,17 41,17 +0,00% 3,41% 1.282
10/11/1994 42,11 43,04 41,17 41,17 -4,35% 4,44% 9.084
09/11/1994 45,38 45,38 43,04 43,04 -5,15% 5,15% 3.740
08/11/1994 45,85 45,85 43,04 45,38 -1,02% 6,12% 1.042
07/11/1994 45,85 45,85 45,85 45,85 +0,00% 0,00% 0
04/11/1994 45,85 45,85 45,85 45,85 +3,16% 0,00% 27
03/11/1994 43,04 45,85 43,04 44,45 -3,06% 6,52% 989
02/11/1994 41,17 45,85 41,17 45,85 +13,95% 11,36% 3.820
01/11/1994 40,24 40,24 40,24 40,24 -5,49% 0,00% 80
31/10/1994 40,24 43,04 40,24 42,58 +5,81% 6,98% 3.473
28/10/1994 43,04 43,98 40,24 40,24 -8,51% 8,70% 6.091
27/10/1994 45,85 45,85 43,98 43,98 -4,08% 4,08% 1.256
26/10/1994 45,85 45,85 45,85 45,85 +0,00% 0,00% 27
25/10/1994 45,85 45,85 44,92 45,85 -2,00% 2,04% 481
24/10/1994 46,79 46,79 46,79 46,79 +0,00% 0,00% 0
21/10/1994 44,92 46,79 44,92 46,79 +0,00% 4,17% 134
20/10/1994 44,92 46,79 44,92 46,79 +4,17% 4,17% 53
19/10/1994 46,79 46,79 44,92 44,92 -4,00% 4,00% 1.176
18/10/1994 46,79 46,79 44,92 46,79 +2,04% 4,00% 53
17/10/1994 47,72 47,72 45,85 45,85 -1,01% 3,92% 10.740
14/10/1994 45,85 46,79 45,85 46,32 -2,94% 2,04% 11.889
13/10/1994 48,66 48,66 45,85 47,72 -1,92% 5,77% 1.843
12/10/1994 45,85 48,66 45,85 48,66 +5,05% 6,12% 48.972
11/10/1994 48,66 48,66 45,85 46,32 +1,02% 5,77% 1.042